Senior Director, Market Access Strategy, International

BridgeBio Pharma seeks a Senior Director for International Market Access Strategy based in Zug. This role leads pricing, reimbursement, and payer engagement across global markets to ensure timely patient access to transformative medicines.

Reporting to the VP of Market Access, International, this position sits at the heart of the company’s global commercial efforts. The incumbent shapes the value narrative and directs pricing and reimbursement strategies across diverse territories. By aligning regional teams and contributing to global decisions, the role ensures that the company’s mission to deliver transformative medicines reaches patients worldwide in a sustainable manner.

Responsibilities

• Act as the payer voice within cross-regional commercial teams to refine pricing and access approaches.
• Partner with HEOR, marketing, and clinical development leaders to align value and access optimization efforts.
• Manage early engagement with key health technology assessment bodies and payers, such as NICE UK and G-BA Germany, to guide evidence generation, value propositions, and dossier preparation.
• Collaborate with internal and external experts—including pricing specialists, health economists, patient advocates, and policymakers—to achieve pricing and reimbursement targets.
• Train and support local access teams on negotiation tactics, ensuring HTA and reimbursement submissions align with global and international strategies.
• Create and implement international market access strategies, including payer evidence generation, to support pricing and reimbursement goals.
• Establish and roll out international pricing strategies and contracting frameworks.
• Advise local teams on reimbursement dossier development, access pathways, and negotiation tactics.

Requirements

• Proven track record of leading HTA submissions and pricing negotiations across multiple international markets, preferably in rare diseases or orphan indications.
• Deep understanding of international healthcare systems, pricing structures, reimbursement frameworks, and regulatory landscapes.
• Experience in generating and applying data for HTA submissions and pricing negotiations, backed by a robust external network of agencies and stakeholders.
• Ability to present at senior levels and engage with global thought leaders.
• Demonstrated success managing complex, cross-functional, and multicultural teams, including external partners.
• Familiarity with product commercialization processes and a hands-on, solution-oriented approach to building scalable processes and documentation.

What the company offers

• Competitive compensation package.
• 401(k) retirement plan with employer match.
• Employee Stock Purchase Program (ESPP).
• Pre-tax commuter benefits for transit and parking.
• Referral bonuses for successful candidate introductions.
• Subsidized lunch and parking on days spent in the office.
• 100% employer-paid medical, dental, and vision premiums for employees and dependents.
• Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA).
• Fertility and family-forming benefits.
• Expanded mental health support, including therapy and coaching resources.
• Hybrid work model with flexibility.
• Flexible paid time off and company-paid holidays.
• Comprehensive paid medical and parental leave.
• Career development through regular feedback, continuous education, and professional programs via LinkedIn Learning, LifeLabs, and BetterUp Coaching.
• Performance-based financial rewards, peer recognition, and growth opportunities.

About the company

BridgeBio Pharma operates as a global biotechnology company with headquarters in San Francisco and an international hub in Zug, Switzerland. The company pioneered a unique approach to biotech by pooling promising early-stage academic research under one financial umbrella to reduce risk and accelerate innovation. BridgeBio is dedicated to building bridges to groundbreaking advancements in rare diseases, developing life-changing medicines for patients with unmet needs as quickly as possible. The culture is energetic and collaborative, where pragmatism meets bold decision-making. The company embraces uncertainty with confidence, driven by a commitment to making a meaningful impact for patients. Employees are trusted and empowered, united by urgency, purpose, and a shared drive to advance science for patients worldwide.

• Innovative 'moneyball' approach to biotech, pooling early-stage research to reduce risk and unleash innovation.
• Mission-driven focus on developing life-changing medicines for rare diseases and unmet patient needs.
• Values curiosity, experimentation, and the ethical use of AI to improve work clarity, speed, and quality.
• Global presence with headquarters in San Francisco and international hub in Zug, Switzerland.
• Empowered, high-performing teams that move quickly, take ownership, and fuel international growth.
• Energetic and collaborative culture blending pragmatism with bold decision-making.
• Embraces uncertainty with confidence, guided by a commitment to patient impact.
• Culture of trust and empowerment, united by urgency, purpose, and a drive to advance science.